Message #19 From:
Stock News Bot Date: September 27, 2006 11:59:00 AM
EMFP News Emergency Filtration Products Launches E.L.V.I.S at NAEMT & EMS Expo in Las Vegas
HENDERSON, Nev.--(BUSINESS WIRE)--Emergency Filtration Products, Inc. (EFP) (OTCBB: EMFP) today launched
E.L.V.I.S. (Emergency Life-support Ventilation and Intubation System) at
the NAEMT (National Association of Emergency Medical Technicians) & EMS
(Emergency Medical Services) Expo in Las Vegas.
EFP's ELVIS is a best-of-breed emergency resuscitation system with
essential integrated features, including a patented medication/suction
port, a self-contained nebulizer and a 2H Technology™
air filtration system that reduces exposure to infectious agents. ELVIS
will be marketed to the U.S. military, hospitals, police and fire
departments, and emergency response teams nationwide.
ELVIS has been endorsed by Catholic Healthcare West (see below) and the
City of Los Angeles Police Department. The company intends to apply for
fast-track FDA approval. Based on current indications of interest for
this product, the company is planning for an initial production run of
10,000 units. The preliminary suggested retail selling price for the
product is $24.95.
About Emergency Filtration Products, Inc.
EFP (http://www.emergencyfiltration.com)
is an air filtration products manufacturer whose patented 2H Technology™
filter system has produced filtration efficiencies of "greater than
99.99%" at a particulate size of 0.027 microns. Its initial products
were developed for the medical market: the Vapor Isolation Valve™
and RespAide® CPR Isolation Mask used for
resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing
Circuit Filter for ventilators, respirators and anesthesia circuitry.
Each has received FDA approval. The company also markets an Automated
External Defibrillator Prep Kit featuring RespAide; and the NanoMask(R),
a nanotechnology-enhanced environmental mask. In addition to filtration
products, the company supplies Superstat(R), a modified hemostatic
collagen, to the U.S. military for surgery and extreme wound care.
Safe Harbor Statement
This release may contain statements that are forward looking. Such
statements are made based upon current expectations that are subject to
risk and uncertainty. EFP does not undertake to update forward-looking
statements in this news release to reflect actual results of and changes
in assumptions or changes in other factors affecting such
forward-looking information. The actual future results of the company
could differ significantly from such forward-looking statements. Sales
may be dependent on the success of future marketing campaigns, and both
the perceived need for EFP's products and the competitive performance of
such products in the marketplace.
